v3.25.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (8,227) $ (5,936)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 982 922
Noncash lease expense 65
Depreciation expense 1
Change in fair value of common warrants classified as a liability (409) (2,103)
Changes in operating assets and liabilities:    
Accounts receivable (126)
Inventory (272)
Prepaid expenses (22) (276)
Other current assets 158
Deferred offering costs 101
Accounts payable 283 125
Accrued expenses (386) 472
Net cash used in operating activities (7,953) (6,695)
Cash flows from investing activities:    
Purchase of property and equipment (2)
Net cash used in investing activities (2)
Cash flows from financing activities:    
Gross proceeds from equity financing 12,102 15,016
Issuance costs from equity financing (1,299)
Proceeds from exercise of common warrants 25
Proceeds from exercise of stock options 17 69
Net cash provided by financing activities 10,845 15,085
Net increase in cash and cash equivalents 2,890 8,390
Beginning of period 7,154 1,173
End of period 10,044 9,563
Supplemental Disclosure of Cash Flow Activities:    
Cash paid for income tax 2
Cash paid for interest
Supplemental Disclosure of Noncash Financing Activities:    
Fair value of common warrant classified as a liability $ 1,188

Source

PDF HTML 10-Q Filing
ZIP XBRL